Fourth Quarter 2021 Investor Presentation

FORWARD-LOOKING STATEMENTS 2 This document contains statements that may constitute “forward-looking statements” within the meaning of Federal securities laws including under “2022 Financial Outlook” in this presentation. Such forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors concerning the Company’s operations and business environment. Important factors that could cause actual results to differ materially from those suggested by these forward-looking statements and that could adversely affect the Company’s future financial performance include the following: the impact and uncertainty created by the ongoing COVID-19 pandemic, including, but not limited to, its effects on our employees, facilities, customers, and suppliers, the availability and cost of raw materials, energy, and other supplies, the availability and cost of labor, logistics, and transportation, governmental regulations and restrictions, and general economic conditions, including inflation; the pace and nature of new product introductions by the Company and the Company’s customers; the Company’s ability to anticipate and respond to changing consumer preferences and changing technologies; the Company’s ability to successfully implement its growth strategies; the outcome of the Company’s various productivity-improvement and cost-reduction efforts, acquisition and divestiture activities, and operational improvement plan; the effectiveness of the Company’s past restructuring activities; changes in costs of raw materials, including energy; industry, regulatory, legal, and economic factors related to the Company’s domestic and international business; the effects of tariffs, trade barriers, and disputes; growth in markets for products in which the Company competes; industry and customer acceptance of price increases; actions by competitors; currency exchange rate fluctuations; and other factors included in “Risk Factors” in the Company's Annual Report on Form 10-K for the year ended December 31, 2020, and in other documents that the Company files with the SEC. The risks and uncertainties identified above are not the only risks the Company faces. Additional risks and uncertainties not presently known to the Company or that it currently believes to be immaterial also may adversely affect the Company. Should any known or unknown risks and uncertainties develop into actual events, these developments could have material adverse effects on our business, financial condition, and results of operations. This presentation contains time-sensitive information that reflects management’s best analysis only as of the date of this presentation. Except to the extent required by applicable laws, the Company does not undertake to publicly update or revise its forward-looking statements even if experience or future changes make it clear that any projected results expressed or implied herein will not be realized.

NON-GAAP FINANCIAL MEASURES 2 Within this document, the Company reports certain non-GAAP financial measures, including: (1) adjusted revenue, adjusted operating income, adjusted net earnings, adjusted EBITDA, and adjusted diluted earnings per share (which exclude divestiture & other related costs, the results of the divested product lines, restructuring and other costs, which include operational improvement plan costs and income, and the 2020 one-time COVID-19 employee payment) (2) adjusted results by segment (which exclude divestiture & other related costs, operational improvement plan costs and income, and the results of the divested operations), (3) percentage changes in revenue, operating income, diluted earnings per share, and EBITDA on an adjusted local currency basis (which eliminate the effects that result from translating its international operations into U.S. dollars, divestiture & other related costs, the results of the divested product lines, restructuring and other costs, which include operational improvement plan costs, and the 2020 one-time COVID-19 employee payment), and (4) adjusted EBITDA (which excludes depreciation and amortization expense, non-cash share based compensation expense, the results of the divested product lines, the divestiture & other related costs, operational improvement plan costs and income, and the 2020 one-time COVID-19 employee payment). The Company has included each of these non-GAAP measures in order to provide additional information regarding the underlying operating results and comparable period- over-period performance. Such information is supplemental to information presented in accordance with GAAP and is not intended to represent a presentation in accordance with GAAP. These non-GAAP measures should not be considered in isolation. Rather, they should be considered together with GAAP measures and the rest of the information included in this presentation and the Company’s SEC filings. Management internally reviews each of these non-GAAP measures to evaluate performance on a comparative period-to-period basis and to gain additional insight into underlying operating and performance trends. The Company believes this information can be beneficial to investors for these same purposes. These non-GAAP measures may not be comparable to similarly titled measures used by other companies. Refer to “Non-GAAPFinancial Measures” at the end of this presentation for reconciliations and additional information.

Sensient Overview 2 Provider of customized solutions for food and beverage, pharmaceutical, and personal care customersGlobal market leader offering an extensive portfolio of natural flavor and color technology platforms and solutionsExceptional innovation & applications expertise with unique ability to service global, regional, and local customers

Innovative Technologies Creating Unique Solutions 2 Applications expertise and solutions-based sellingHigh impact relative to costTechnically-driven products that are difficult to replace Strong consumer trendsOpportunities to grow organically and through M&A

Focusing our portfolio and strengthening our commitment to the end markets 2 Investing in core focus areas of Flavors and Extracts, Natural Ingredients, Food and Pharmaceutical Colors, and Personal CareDivested non-core product lines (inks, fragrances, and yogurt fruitprep product lines) in 2020 and 2021Expanded flavor portfolio and strengthened technical solutions capabilities through the acquisition of Flavor Solutions, Inc. on July 15, 2021

Natural solutions provider focused on consistent and sustainable supply chain 2 Provider of natural solutions to support health & wellness and clean label consumer trendsRobust agronomy program ensures responsible procurement and traceability of sustainable ingredientsCommitted to delivering safe, authentic, high-quality natural products through Sensient’s CertasureTM program

8 Color Group2021 Revenue: $545M 2021 Adj. Revenue*: $543M Core Areas of Focus: Food and Pharmaceutical Colors and Personal CareFlavors & Extracts Group2021 Revenue: $739M 2021 Adj. Revenue*: $712M Core Areas of Focus: Natural Flavors, Extracts and Natural IngredientsAsia Pacific Group2021 Revenue: $135M 2021 Adj. Revenue*: $135M Core Areas of Focus: Flavors and Colors for food and beverage Global Revenue by Group 2021 Global Revenues include intercompany sales which are eliminated on a consolidated basis.*Adj. Revenue is a Non-GAAP metric, please see our GAAP to Non-GAAP Reconciliation at the end of this document.

9 Global market leaderNatural color innovatorExcellent innovation & applications expertise Color Group

10 Color Overview Food and Pharmaceutical 71% of Segment Revenue 71% of Adj. Segment Revenue LC Revenue ChangeQ4 ’21 +15.6%YTD ’21 +9.4% Market trend toward natural colors in food and beverageUnique value proposition for Pharmaceutical customers includescolors, flavors, coatings, and extracts Personal Care 29% of Segment Revenue 29% of Adj. Segment Revenue LC Revenue ChangeQ4 ’21 +16.3%YTD ’21 +9.3% Demand for innovative products with multiple benefitsProduct line includes formulation aides and ingredients for colorcosmetics, hair care, and skin careRecovery from negative COVID impacts ongoing Inks Inks divested in June 2020 2021 Revenue: $545M 2021 Adj. Revenue*: $543M *Local-currency (LC) revenue and adjusted revenue are Non-GAAP metrics, please see our GAAP to Non- GAAP Reconciliation at the end of this document.

11 Flavors & Extracts Group Broad product offeringUnique ability to service global, regional, and local customersLeading technology platformsOutstanding applications expertise

12 Flavors & Extracts Overview Flavors, Extracts, and Flavor Ingredients 62% of Segment Revenue 64% of Adj. Segment Revenue LC Revenue Change Q4 ’21 +11.8%YTD ’21 +11.9% Opportunities for on trend products with extracts, taste modulation, and natural flavors NaturalIngredients 35% of Segment Revenue 36% of Adj. Segment Revenue LC Revenue ChangeQ4 ’21 +2.4%YTD ’21 +5.1% Leading provider of dehydrated onion, garlic, and other products Fragrances & Yogurt Fruit Prep 3% of Segment Revenue Yogurt Fruit Prep divested September 2020Fragrances divested April 2021 2021 Revenue: $739M 2021 Adj. Revenue*: $712M *Local-currency (LC) revenue and adjusted revenue are Non-GAAP metrics, please see our GAAP to Non- GAAP Reconciliation at the end of this document.

13 Asia Pacific Group Portfolio of food and beverage flavors and colorsR&D centers in Singapore, Thailand, and China to support local and regional customer baseAbility to deliver localized solutionsand technology platforms

14 2021 adjusted revenue of $135 million and adjusted operating income of $26 millionSensient’s sales of flavors and colors for Food and Pharmaceutical are managed on a geographic basis and reported as a separate segmentManufacturing capabilities in Australia, New Zealand, China, Japan, Philippines, Thailand, and IndiaQ4 2021 local currency adjusted revenue and operating profit improved15.0% and 24.9%, respectively * Adjusted revenue, local currency adjusted revenue, adjusted operating income, and local currency adjusted operating income are Non-GAAP metrics. Please see our GAAP to Non-GAAP Reconciliation at the end of this document. Asia Pacific Overview

15 2021 Q4 Segment Results Local Currency Adjusted Revenue* Local Currency Adjusted* Commentary: Q4 YTD Color Group reported higher revenue in the quarter due to double digit growth in Personal Care and continued strength in Food and Pharmaceutical driven by new product launches and demand in natural food and beverage colors. Operating income was up in the quarter due to volume. Color +15.8% +9.4% Flavors & Extracts +8.0% +9.4% Asia Pacific +15.0% +10.1% Flavors & Extracts Group fourth quarter revenue increase was driven by volume growth in all product categories. Flavor Solutions acquisition contributed $3 million, or 1.9%, of growth in the quarter. Operating income was up as a result of the higher volumes and product mix.Asia Pacific Group fourth quarter revenue increased double digits driven by volume growth in almost all regions. Operating income improved in the quarter due to volume growth. Local Currency Adjusted OperatingIncome* Q4 YTD Color +19.1% +4.8% Flavors & Extracts +10.6% +15.2% Asia Pacific +24.9% +21.6% * Local-currency (LC) adjusted revenue and adjusted operating income are Non-GAAP metrics. Please see our GAAP to Non-GAAP Reconciliation at the end of this document.

16 2021 Q4 Consolidated Results Q4 YTD Local Currency Adjusted Revenue* +10.7% +9.1% Local Currency Adjusted Operating Income* +14.6% +8.3% Local Currency Adjusted Diluted EPS* +21.3% +10.0% Local Currency Adjusted EBITDA* +14.7% +8.6% Q4 consolidated local currency adjusted revenue was up double digits due to strong growth across all of the groups primarily as a result of volume growth driven by new customer sale wins. Personal Care revenue grew double digits driven by the group’s diversification strategy and ongoing recovery in color make-up.Q4 consolidated local currency adjusted operating income was up due to the overall volume growth across our businesses; however, the operating income improvement was partially offset due to higher year-over-year Corporate expenses related to performance-based compensation and timing of pricing actions related to higher raw material costs. * Local-currency (LC) adjusted revenue, adjusted operating income, adjusted diluted EPS, and adjusted EBITDA are Non-GAAP metrics. Please see our GAAP to Non-GAAP Reconciliation at the end of this document.

Capital Allocation Prioritize ROI capital projects Maintain financial flexibility to pursueM&A Dividend payout increased 5.1% in 2021 Excess capital returned to shareholdersthrough opportunistic share repurchases $87 $77 $43 $54 $57 $62 $66 $67 $56 $51 $39 $52 $61 $31 $14 $9 $87 $118 $- $50 $100 $150 $200 $250 2017 2018 2019 2020 2021 DOLLARS IN MILLIONS Share Repurchase Acquisitions Dividends Debt Repayments Capital Expenditures 17

2022 Financial Outlook 18 Metric Guidance* Comments Diluted EPS (GAAP) Mid-teen growth At current rates, we anticipate a FX headwind of approximately 10 cents Local Currency Diluted EPS* High single digit growth Local Currency Revenue* Mid-single digit growth Adjusted Local Currency EBITDA* High single digit growth Excludes the impact of share-based stock compensation *In 2022, the Company does not anticipate any impact to the above metrics as a result of divestiture & other related costs, operational improvement plancosts, or the results of the divested operations.The 2022 Local Currency Diluted EPS, Local Currency Revenue and Adjusted Local Currency EBITDA growth rates for 2022 are compared to the 2021 Adjusted Diluted EPS, Adjusted Revenue and Adjusted EBITDA, respectively, which excluded the divestiture & other related costs, operational improvement plan costs and the results of operations of the divested product lines. Adjusted revenue, adjusted diluted EPS and adjusted EBITDA are Non-GAAP metrics. Please see our GAAP to Non-GAAP Reconciliation at the end of this document.

Why Invest? Strong competitive positionDefensible and ‘Sticky’ business (& low portion ofcustomer costs)Global presenceExposure to stable and growing markets Focused on improving returns and on growth 19

APPENDIX* *Amounts in thousands, except percentages and per share amounts

ESG Information Click here to access our Environmental Sensient is committed to the principles of sound environmental stewardship and the responsible and sustainable use of energy and natural resources.Long-term goals to reduce Energy, Water, and Hazardous Waste intensitySeed-to-shelf program focused on sustainable supply chainEmphasis on new products and technologies that minimize waste and environmental impactsChemical Risk Strategy implemented to identify and reduce risk in our portfolio Social Sensient strives to conduct business in an ethical manner and to make a positive contribution to society through our product offerings and business activities.Sensient’s Code of Conduct and Supplier Code of Conduct require strong ethical behavior, fair employment practices, and strict human rights practices and product safety standardsRobust product, environmental, and raw material safety programs designed to exceed industry standards.Raw material traceability and sustainability programsSupport for our local communities through volunteerism, financial donations, sponsorships, and employee education opportunities Governance Sensient is committed to maintaining the highest standards of professional conduct and strong corporategovernance practices through our comprehensive corporate governance framework.Board comprised of a majority of independent directors with diverse and accomplished backgroundsCommitted to board diversity and refreshment, we were recognized by 50/50 Women on Boards for the tenth year in a row and we have added seven new directors since 2014.Robust Code of Conduct built on a foundation of ethics, safety and quality, and professionalism resulting in ethical and lawful conduct of our business 21

22 Non-GAAP Financial Measures Note: EPS Calculations may not foot due to rounding differences Three Months Ended December 31, 2021$ 340,448 Year Ended December 31, 2021 Year Ended December 31, 2020$ 1,332,001 Revenue (GAAP) 1,380,264 Three Months Ended December 31, 2020$ 334,668 $ Revenue of the divested product lines (663) (25,163) (30,062) (113,553) Adjusted revenue $ 339,785 $ 309,505 $ 1,350,202 $ 1,218,448 Operating income (GAAP) $ 40,420 $ 34,815 $ 170,028 $ 152,656 Divestiture & other related costs (income) – Cost of products sold 58 4 86 1,795 Divestiture & other related costs – Selling and administrative expenses 579 1,671 14,052 10,360 Operating loss (income) of the divested product lines 518 (3,415) (1,880) (7,580) Operational improvement plan - Cost of products sold - - - 35 Operational improvement plan - Selling and administrative expenses (income) 115 698 (1,895) 3,304 COVID-19 employee payment - Cost of products sold - 1,036 - 1,036 COVID-19 employee payment - Selling and administrative expenses - 1,986 - 1,986 Adjusted operating income $ 41,690 $ 36,795 $ 180,391 $ 163,592 Net earnings (GAAP) $ 27,229 $ 25,169 $ 118,745 $ 109,472 Divestiture & other related costs, before tax 637 1,675 14,138 12,155 Tax impact of divestiture & other related costs 1,809 (1,393) 2,092 (2,605) Net loss (earnings) of the divested product lines, before tax 518 (3,415) (1,880) (7,580) Tax impact of the divested product lines (130) 790 460 1,945 Operational improvement plan costs (income), before tax 115 698 (1,895) 3,339 Tax impact of operational improvement plan 427 (170) 471 (826) COVID-19 employee payment, before tax - 3,022 - 3,022 Tax impact of COVID-19 employee payment - (675) - (675) Adjusted net earnings $ 30,605 $ 25,701 $ 132,131 $ 118,247 Diluted earnings per share (GAAP) $ 0.65 $ 0.59 $ 2.81 $ 2.59 Divestiture & other related costs (income), net of tax 0.06 0.01 0.38 0.23 Results of operations of the divested product lines, net of tax 0.01 (0.06) (0.03) (0.13) Operational improvement plan costs (income), net of tax 0.01 0.01 (0.03) 0.06 COVID-19 employee payment, net of taxAdjusted diluted earnings per share - 0.06 - 0.06 $ 0.73 $ 0.61 $ 3.13 $ 2.79

Non-GAAP Financial Measures (Cont’d) 23 Revenue Total ForeignExchange Rates Adjustments* AdjustedLocal Currency Total ForeignExchange Rates Adjustments* AdjustedLocal Currency Flavors & Extracts (6.1%) (0.7%) (13.4%) 8.0% (0.4%) 1.6% (11.4%) 9.4% Color 14.4% (1.1%) (0.3%) 15.8% 8.8% 2.1% (2.7%) 9.4% Asia Pacific 11.1% (3.5%) (0.4%) 15.0% 11.6% 1.7% (0.2%) 10.1% Total Revenue 1.7% (1.2%) (7.8%) 10.7% 3.6% 1.8% (7.3%) 9.1% Operating IncomeFlavors & Extracts (6.7%) (0.7%) (16.6%) 10.6% 8.4% 1.2% (8.0%) 15.2% Color 17.3% (0.8%) (1.0%) 19.1% 7.9% 2.6% 0.5% 4.8% Asia Pacific 18.9% (5.1%) (0.9%) 24.9% 19.3% (1.8%) (0.5%) 21.6% Corporate & Other (16.1%) 0.0% (38.2%) 22.1% 3.7% 0.0% (18.4%) 22.1% Total Operating Income 16.1% (1.8%) 3.3% 14.6% 11.4% 2.1% 1.0% 8.3% Diluted Earnings Per Share 10.2% (1.7%) (9.4%) 21.3% 8.5% 1.9% (3.4%) 10.0% Adjusted EBITDA 13.5% (1.2%) N/A 14.7% 10.6% 2.0% N/A 8.6% * For Revenue, adjustments consist of revenues of the divested product lines. For Operating Income, Diluted Earnings per Share, and Adjusted EBITDA, adjustments consist of the results of the divested product lines, divestiture & other related costs, operational improvement plan costs and income, and the 2020 COVID-19 employee payment. Three Months Ended December 31, 2021 Year Ended December 31, 2021

Non-GAAP Financial Measures (Cont’d) 24 2021 2020 % Change 2021 2020 % Change Operating income (GAAP) $ 40,420 $ 34,815 16.1% $ 170,028 $ 152,656 11.4% Depreciation and amortization 13,223 12,810 52,051 49,641 Depreciation and amortization, divested product lines - (48) (146) (193) Share-based compensation expense 3,142 1,591 9,573 5,608 Divestiture & other related costs, before tax 637 1,675 14,138 12,155 Results of operations of the divested product lines, before tax 518 (3,415) (1,880) (7,580) Operational improvement plan costs (income), before tax 115 698 (1,895) 3,339 COVID-19 employee payment, before tax - 3,022 - 3,022 Adjusted EBITDA $ 58,055 $ 51,148 13.5% $ 241,869 $ 218,648 10.6% Three Months Ended December 31, Year Ended December 31,

Non-GAAP Financial Measures (Cont’d) 25 Note: *Fragrances was divested in April 2021, Inks was divested in June 2020, and Yogurt Fruit Prep was divested in September 2020. Revenue Total Exchange Rates Local Currency Total Exchange Rates Local Currency Flavors, Extracts and Flavor Ingredients 11.2% (0.6%) 11.8% 14.1% 2.2% 11.9% Natural Ingredients 2.4% 0.0% 2.4% 5.2% 0.1% 5.1% Fragrances* (100.0%) (4.0%) (96.0%) (73.4%) 3.7% (77.1%) Yogurt Fruit Prep* (90.3%) 0.0% (90.3%) (64.1%) 0.0% (64.1%) Flavors & Extracts Group (6.1%) (0.7%) (5.4%) (0.4%) 1.6% (2.0%) Food and Pharmaceutical 14.6% (1.0%) 15.6% 11.5% 2.1% 9.4% Personal Care 15.0% (1.3%) 16.3% 11.5% 2.2% 9.3% Inks* (22.5%) 0.0% (22.5%) (85.4%) 1.8% (87.2%) Color Group 14.4% (1.1%) 15.5% 8.8% 2.1% 6.7% Asia Pacific 11.1% (3.5%) 14.6% 11.6% 1.7% 9.9% Total revenue including the productlines divested 1.7% (1.2%) 2.9% 3.6% 1.7% 1.9% Three Months Ended December 31, 2021 Year Ended December 31, 2021 Foreign Foreign

Q4 Results of Operations 26 Results by Segment Three Months Ended December 31, Revenue 2021 Adjustments* Adjusted 2021 2020 Adjustments* Adjusted 2020 Flavors & Extracts $ 177,448 $ (221) $ 177,227 $ 189,060 $ (24,378) $ 164,682 Color 137,104 (442) 136,662 119,813 (766) 119,047 Asia Pacific 35,749 - 35,749 32,165 (116) 32,049 Intersegment elimination (9,853) - (9,853) (6,370) 97 (6,273) Consolidated $ 340,448 $ (663) $ 339,785 $ 334,668 $ (25,163) $ 309,505 Operating Income Flavors & Extracts $ 21,942 $ 491 $ 22,433 $ 23,507 $ (3,214) $ 20,293 Color 24,113 27 24,140 20,548 (158) 20,390 Asia Pacific 7,184 - 7,184 6,044 (43) 6,001 Corporate & Other (12,819) 752 (12,067) (15,284) 5,395 (9,889) Consolidated $ 40,420 $ 1,270 $ 41,690 $ 34,815 $ 1,980 $ 36,795 * For Revenue, adjustments consist of revenues of the divested product lines. For Operating Income, adjustments consist of the results of the divested product lines, divestiture & other related costs, operational improvement plan costs and income, and the 2020 COVID-19 employee payment.

Q4 YTD Results of Operations 27 Results by Segment Year Ended December 31, Revenue 2021 Adjustments* Adjusted 2021 2020 Adjustments* Adjusted 2020 Flavors & Extracts $ 739,427 $ (27,837) $ 711,590 $ 742,035 $ (99,543) $ 642,492 Color 545,270 (2,080) 543,190 501,018 (14,008) 487,010 Asia Pacific 135,348 (295) 135,053 121,227 (518) 120,709 Intersegment elimination (39,781) 150 (39,631) (32,279) 516 (31,763) Consolidated $ 1,380,264 $ (30,062) $ 1,350,202 $ 1,332,001 $ (113,553) $ 1,218,448 Operating Income Flavors & Extracts $ 98,660 $ (2,368) $ 96,292 $ 90,974 $ (8,292) $ 82,682 Color 103,575 575 104,150 96,034 871 96,905 Asia Pacific 26,330 (87) 26,243 22,075 (159) 21,916 Corporate & Other (58,537) 12,243 (46,294) (56,427) 18,516 (37,911) Consolidated $ 170,028 $ 10,363 $ 180,391 $ 152,656 $ 10,936 $ 163,592 * For Revenue, adjustments consist of revenues of the divested product lines. For Operating Income, adjustments consist of the results of the divested product lines, divestiture & other related costs, operational improvement plan costs and income, and the 2020 COVID-19 employee payment.